Splenic artery pulsatility index is a simple, non-invasive and reproducible technique for assessing hepatic fibrosis in patients with
chronic hepatitis C and can reduce the number of staging liver biopsies.
The impact of obesity and metabolic syndrome on
chronic hepatitis C.
Suzuki et al., "Sustained virological response reduces incidence of onset of type 2 diabetes in
chronic hepatitis C," Hepatology, vol.
Chronic hepatitis C virus (HCV) disease burden and cost in the United States.
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for
chronic hepatitis B: A 5-year open-label follow-up study.
Treatment of
chronic hepatitis C in polytransfusedthalassaemic patients: a meta?analysis.
Patients with
chronic hepatitis C had a nearly 25-fold greater risk of being hospitalized with liver-related conditions, compared with other health system patients.
Chronic hepatitis B is usually defined by the presence of hepatitis B surface antigen in the blood or serum for longer than 6 months.
The program aims to improve the capacity of health care providers and stakeholder groups to reduce the burden of
chronic hepatitis B in Asian American and other at-risk communities through increased hepatitis B education, screening, vaccination, and linkage to care.
So, the logical question arises for clinicians, should all patients with diagnosed NAFLD be screened for
chronic hepatitis C?
Medivir AB (STO:MVIRB.ST), a research-based pharmaceutical company focused on infectious diseases, announced today the approval by the Russian Ministry of Health of Sovriad (simeprevir) for the treatment of
chronic hepatitis C genotype 1 infection in combination with pegylated interferon and ribavirin in HCV genotype 1 and 4 infected patients with compensated liver disease, including cirrhosis.
Chronic hepatitis B remains the most common serious health problem in the world, especially in the Asia Pacific region.